{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T14:30:43Z","timestamp":1792765843291,"version":"4.5.0"},"reference-count":120,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T00:00:00Z","timestamp":1725321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T00:00:00Z","timestamp":1725321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s00210-024-03397-w","type":"journal-article","created":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T11:02:06Z","timestamp":1725361326000},"page":"1081-1097","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Can infliximab serve as a new therapy for neuropsychiatric symptoms?"],"prefix":"10.1007","volume":"398","author":[{"given":"Fatemeh","family":"Rahmati-Dehkordi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nafiseh","family":"Birang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Naser","family":"Jalalian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeinab","family":"Tamtaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehsan","family":"Dadgostar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Aschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Shafiee Ardestani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed","family":"Jafarpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed","family":"Mirzaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Nabavizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omid Reza","family":"Tamtaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,3]]},"reference":[{"issue":"12","key":"3397_CR1","doi-asserted-by":"crossref","first-page":"5991","DOI":"10.1210\/en.2007-0132","volume":"148","author":"EP Ara\u00fajo","year":"2007","unstructured":"Ara\u00fajo EP, De SouzaUeno CM, Cintra DE, Bertolo MB, Carvalheira JB, Velloso LA (2007) Infliximab restores glucose homeostasis in an animal model of diet-induced obesity and diabetes. Endocrinol 148(12):5991\u20135997","journal-title":"Endocrinol"},{"issue":"3","key":"3397_CR2","doi-asserted-by":"crossref","first-page":"AB175","DOI":"10.1016\/j.jaad.2022.06.731","volume":"87","author":"A Armstrong","year":"2022","unstructured":"Armstrong A, McBride S, Spelman L, Fern\u00e1ndez-Pe\u00f1as P, Rich P, Martin G, Hellot S (2022) 33259 Improvements in anxiety and depression among patients with moderate to severe plaque psoriasis treated with certolizumab pegol: three-year results from 2 phase 3 trials (CIMPASI-1 and CIMPASI-2). J Am Acad Dermatol 87(3):AB175","journal-title":"J Am Acad Dermatol"},{"key":"3397_CR3","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijcard.2021.02.022","volume":"330","author":"A Bakker","year":"2021","unstructured":"Bakker A, Mathijssen H, Azzahhafi J, Swaans M, Veltkamp M, Keijsers R, Grutters J (2021) Effectiveness and safety of infliximab in cardiac sarcoidosis. Int J Cardiol 330:179\u2013185","journal-title":"Int J Cardiol"},{"issue":"3","key":"3397_CR4","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.jhep.2019.01.008","volume":"73","author":"T Balzano","year":"2020","unstructured":"Balzano T, Dadsetan S, Forteza J, Cabrera-Pastor A, Taoro-Gonzalez L, Malaguarnera M, Felipo V (2020) Chronic hyperammonemia induces peripheral inflammation that leads to cognitive impairment in rats: reversed by anti-TNF-\u03b1 treatment. J Hepatol 73(3):582\u2013592. https:\/\/doi.org\/10.1016\/j.jhep.2019.01.008","journal-title":"J Hepatol"},{"key":"3397_CR5","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.psyneuen.2018.09.004","volume":"98","author":"M Bekhbat","year":"2018","unstructured":"Bekhbat M, Chu K, Le NA, Woolwine BJ, Haroon E, Miller AH, Felger JC (2018) Glucose and lipid-related biomarkers and the antidepressant response to infliximab in patients with treatment-resistant depression. Psychoneuroendocrinology 98:222\u2013229. https:\/\/doi.org\/10.1016\/j.psyneuen.2018.09.004","journal-title":"Psychoneuroendocrinology"},{"issue":"6","key":"3397_CR6","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.3899\/jrheum.130864","volume":"41","author":"CO Bingham","year":"2014","unstructured":"Bingham CO, Weinblatt M, Han C, Gathany TA, Kim L, Lo KH, Westhovens R (2014) The effect of intravenous golimumab on health-related quality of life in rheumatoid arthritis: 24-week results of the phase III GO-FURTHER trial. J Rheumatol 41(6):1067\u20131076","journal-title":"J Rheumatol"},{"key":"3397_CR7","doi-asserted-by":"crossref","unstructured":"Binici S, G\u00fcven M, \u00d6zdemir A, \u0130lik ZA, Demirhan B, Uygur S, \u0130liklerden \u00dcH (2024) Addressing radiotherapy-induced fibrosis: the potential of platelet-rich plasma and infliximab for improved breast cancer management. Histochem Cell Biol 1\u20139","DOI":"10.1007\/s00418-024-02267-z"},{"issue":"1","key":"3397_CR8","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jhep.2021.08.024","volume":"76","author":"HK Bj\u00f6rnsson","year":"2022","unstructured":"Bj\u00f6rnsson HK, Gudbjornsson B, Bj\u00f6rnsson ES (2022) Infliximab-induced liver injury: clinical phenotypes, autoimmunity and the role of corticosteroid treatment. J Hepatol 76(1):86\u201392","journal-title":"J Hepatol"},{"issue":"4","key":"3397_CR9","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1172\/jci57256","volume":"122","author":"TR Bomfim","year":"2012","unstructured":"Bomfim TR, Forny-Germano L, Sathler LB, Brito-Moreira J, Houzel JC, Decker H, De Felice FG (2012) An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer\u2019s disease- associated A\u03b2 oligomers. J Clin Invest 122(4):1339\u20131353. https:\/\/doi.org\/10.1172\/jci57256","journal-title":"J Clin Invest"},{"issue":"3","key":"3397_CR10","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.3233\/JAD-191092","volume":"73","author":"Q Cao","year":"2020","unstructured":"Cao Q, Tan C-C, Xu W, Hu H, Cao X-P, Dong Q, Yu J-T (2020) The prevalence of dementia: a systematic review and meta-analysis. J Alzheimer\u2019s Dis 73(3):1157\u20131166","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"2","key":"3397_CR11","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/acn3.51968","volume":"11","author":"S Chaiyanarm","year":"2024","unstructured":"Chaiyanarm S, Satiraphan P, Apiraksattaykul N, Jitprapaikulsan J, Owattanapanich W, Rungjirajittranon T, Nanthasi W (2024) Infliximab in neurosarcoidosis: a systematic review and meta-analysis. Ann Clin Transl Neurol 11(2):466\u201376","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"3397_CR12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1017\/S1461145711000149","volume":"15","author":"C-H Chen","year":"2012","unstructured":"Chen C-H, Zhou W, Liu S, Deng Y, Cai F, Tone M, Song W (2012) Increased NF-\u03baB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer\u2019s disease. Int J Neuropsychopharmacol 15(1):77\u201390","journal-title":"Int J Neuropsychopharmacol"},{"issue":"2","key":"3397_CR13","doi-asserted-by":"publisher","first-page":"190","DOI":"10.15252\/emmm.201404183","volume":"7","author":"JR Clarke","year":"2015","unstructured":"Clarke JR, Lyra ESNM, Figueiredo CP, Frozza RL, Ledo JH, Beckman D, De Felice FG (2015) Alzheimer-associated A\u03b2 oligomers impact the central nervous system to induce peripheral metabolic deregulation. EMBO Mol Med 7(2):190\u2013210. https:\/\/doi.org\/10.15252\/emmm.201404183","journal-title":"EMBO Mol Med"},{"issue":"1","key":"3397_CR14","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s12974-016-0710-8","volume":"13","author":"S Dadsetan","year":"2016","unstructured":"Dadsetan S, Balzano T, Forteza J, Agusti A, Cabrera-Pastor A, Taoro-Gonzalez L, Felipo V (2016a) Infliximab reduces peripheral inflammation, neuroinflammation, and extracellular GABA in the cerebellum and improves learning and motor coordination in rats with hepatic encephalopathy. J Neuroinflammation 13(1):245. https:\/\/doi.org\/10.1186\/s12974-016-0710-8","journal-title":"J Neuroinflammation"},{"key":"3397_CR15","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3389\/fnmol.2016.00106","volume":"9","author":"S Dadsetan","year":"2016","unstructured":"Dadsetan S, Balzano T, Forteza J, Cabrera-Pastor A, Taoro-Gonzalez L, Hernandez-Rabaza V, Felipo V (2016b) Reducing peripheral inflammation with infliximab reduces neuroinflammation and improves cognition in rats with hepatic encephalopathy. Front Mol Neurosci 9:106. https:\/\/doi.org\/10.3389\/fnmol.2016.00106","journal-title":"Front Mol Neurosci"},{"issue":"4","key":"3397_CR16","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/sj.mp.4000572","volume":"4","author":"R Dantzer","year":"1999","unstructured":"Dantzer R, Wollman E, Vitkovic L, Yirmiya R (1999) Cytokines and depression: fortuitous or causative association? Mol Psychiatry 4(4):328\u2013332","journal-title":"Mol Psychiatry"},{"key":"3397_CR17","doi-asserted-by":"publisher","first-page":"734158","DOI":"10.3389\/fnins.2021.734158","volume":"15","author":"GC de Paula","year":"2021","unstructured":"de Paula GC, Brunetta HS, Engel DF, Gaspar JM, Velloso LA, Engblom D, de Bem AF (2021) Hippocampal function is impaired by a short-term high-fat diet in mice: increased blood-brain barrier permeability and neuroinflammation as triggering events. Front Neurosci 15:734158. https:\/\/doi.org\/10.3389\/fnins.2021.734158","journal-title":"Front Neurosci"},{"issue":"3","key":"3397_CR18","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1159\/000314225","volume":"80","author":"MD Elfferich","year":"2010","unstructured":"Elfferich MD, Nelemans PJ, Ponds RW, De Vries J, Wijnen PA, Drent M (2010) Everyday cognitive failure in sarcoidosis: the prevalence and the effect of anti-TNF-alpha treatment. Respiration 80(3):212\u2013219. https:\/\/doi.org\/10.1159\/000314225","journal-title":"Respiration"},{"issue":"4","key":"3397_CR19","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/j.1440-1819.2010.02096.x","volume":"64","author":"B Elisa","year":"2010","unstructured":"Elisa B, Beny L (2010) Induction of manic switch by the tumour necrosis factor-alpha antagonist infliximab. Psychiatry Clin Neurosci 64(4):442\u2013443. https:\/\/doi.org\/10.1111\/j.1440-1819.2010.02096.x","journal-title":"Psychiatry Clin Neurosci"},{"issue":"3","key":"3397_CR20","first-page":"262","volume":"40","author":"ED Ers\u00f6zl\u00fc-Bozk\u0131rl\u0131","year":"2015","unstructured":"Ers\u00f6zl\u00fc-Bozk\u0131rl\u0131 ED, Ke\u015fkek SO, Bozk\u0131rl\u0131 E, Y\u00fccel AE (2015) The effect of infliximab on depressive symptoms in patients with ankylosing spondylitis. Acta Reumatol Port 40(3):262\u2013267","journal-title":"Acta Reumatol Port"},{"issue":"2","key":"3397_CR21","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00296-010-1616-x","volume":"32","author":"I Ertenli","year":"2012","unstructured":"Ertenli I, Ozer S, Kiraz S, Apras SB, Akdogan A, Karadag O, Kalyoncu U (2012) Infliximab, a TNF-\u03b1 antagonist treatment in patients with ankylosing spondylitis: the impact on depression, anxiety and quality of life level. Rheumatol Int 32(2):323\u2013330. https:\/\/doi.org\/10.1007\/s00296-010-1616-x","journal-title":"Rheumatol Int"},{"issue":"5","key":"3397_CR22","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.crohns.2010.04.001","volume":"4","author":"EJ Eshuis","year":"2010","unstructured":"Eshuis EJ, Magnin KM, Stokkers PC, Bemelman WA, Bartelsman J (2010) Suicide attempt in ulcerative colitis patient after 4 months of infliximab therapy\u2013a case report. J Crohns Colitis 4(5):591\u2013593. https:\/\/doi.org\/10.1016\/j.crohns.2010.04.001","journal-title":"J Crohns Colitis"},{"issue":"5","key":"3397_CR23","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1111\/j.1365-2133.2005.06510.x","volume":"152","author":"SR Feldman","year":"2005","unstructured":"Feldman SR, Gordon KB, Bala M, Evans R, Li S, Dooley LT, Gottlieb AB (2005) Infliximab treatment results in significant improvement in the quality of life of patients with severe psoriasis: a double-blind placebo-controlled trial. Br J Dermatol 152(5):954\u2013960. https:\/\/doi.org\/10.1111\/j.1365-2133.2005.06510.x","journal-title":"Br J Dermatol"},{"issue":"3","key":"3397_CR24","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1111\/j.1365-2133.2008.08727.x","volume":"159","author":"SR Feldman","year":"2008","unstructured":"Feldman SR, Gottlieb AB, Bala M, Wu Y, Eisenberg D, Guzzo C, Menter A (2008) Infliximab improves health-related quality of life in the presence of comorbidities among patients with moderate-to-severe psoriasis. Br J Dermatol 159(3):704\u2013710. https:\/\/doi.org\/10.1111\/j.1365-2133.2008.08727.x","journal-title":"Br J Dermatol"},{"issue":"4","key":"3397_CR25","doi-asserted-by":"crossref","first-page":"526","DOI":"10.55782\/ane-2008-1720","volume":"68","author":"I Figiel","year":"2008","unstructured":"Figiel I (2008) Pro-inflammatory cytokine TNF-alpha as a neuroprotective agent in the brain. Acta Neurobiol Exp 68(4):526\u2013534","journal-title":"Acta Neurobiol Exp"},{"issue":"1","key":"3397_CR26","doi-asserted-by":"publisher","first-page":"3890","DOI":"10.1038\/s41467-019-11866-7","volume":"10","author":"CP Figueiredo","year":"2019","unstructured":"Figueiredo CP, Barros-Arag\u00e3o FGQ, Neris RLS, Frost PS, Soares C, Souza INO, Ferreira ST (2019) Zika virus replicates in adult human brain tissue and impairs synapses and memory in mice. Nat Commun 10(1):3890. https:\/\/doi.org\/10.1038\/s41467-019-11866-7","journal-title":"Nat Commun"},{"issue":"13","key":"3397_CR27","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1097\/wnr.0000000000000637","volume":"27","author":"XY Fu","year":"2016","unstructured":"Fu XY, Li HY, Jiang QS, Cui T, Jiang XH, Zhou QX, Qiu HM (2016) Infliximab ameliorating depression-like behavior through inhibiting the activation of the IDO-HAAO pathway mediated by tumor necrosis factor-\u03b1 in a rat model. NeuroReport 27(13):953\u2013959. https:\/\/doi.org\/10.1097\/wnr.0000000000000637","journal-title":"NeuroReport"},{"issue":"3","key":"3397_CR28","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1080\/03009742.2023.2300887","volume":"53","author":"S Gertel","year":"2024","unstructured":"Gertel S, Rokach M, Polachek A, Litinsky I, Anouk M, Elkayam O, Furer V (2024) Anti-inflammatory effects of infliximab and methotrexate on peripheral blood and synovial fluid mononuclear cells: ex vivo study. Scand J Rheumatol 53(3):188\u201398","journal-title":"Scand J Rheumatol"},{"issue":"3","key":"3397_CR29","doi-asserted-by":"publisher","first-page":"e0193542","DOI":"10.1371\/journal.pone.0193542","volume":"13","author":"MA Gray","year":"2018","unstructured":"Gray MA, Chao CY, Staudacher HM, Kolosky NA, Talley NJ, Holtmann G (2018) Anti-TNF\u03b1 therapy in IBD alters brain activity reflecting visceral sensory function and cognitive-affective biases. PLoS ONE 13(3):e0193542. https:\/\/doi.org\/10.1371\/journal.pone.0193542","journal-title":"PLoS ONE"},{"issue":"5","key":"3397_CR30","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/0092-8674(95)90192-2","volume":"83","author":"M Grell","year":"1995","unstructured":"Grell M, Douni E, Wajant H, L\u00f6hden M, Clauss M, Maxeiner B, Pfizenmaier K (1995) The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83(5):793\u2013802","journal-title":"Cell"},{"issue":"1","key":"3397_CR31","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s00384-023-04378-w","volume":"38","author":"B Han","year":"2023","unstructured":"Han B, Tang D, Lv X, Li S, Fan J, Xu X, Huang Z (2023) Comparative efficacy and safety of combination therapy with infliximab for Crohn\u2019s disease: a systematic review and network meta-analysis. Int J Colorectal Dis 38(1):82","journal-title":"Int J Colorectal Dis"},{"issue":"4","key":"3397_CR32","first-page":"591","volume":"82","author":"R Hernandez-Pando","year":"1994","unstructured":"Hernandez-Pando R, Rook G (1994) The role of TNF-alpha in T-cell-mediated inflammation depends on the Th1\/Th2 cytokine balance. Immunol 82(4):591","journal-title":"Immunol"},{"issue":"10","key":"3397_CR33","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/s41593-018-0242-x","volume":"21","author":"S Hickman","year":"2018","unstructured":"Hickman S, Izzy S, Sen P, Morsett L, El Khoury J (2018) Microglia in neurodegeneration. Nat Neurosci 21(10):1359\u20131369","journal-title":"Nat Neurosci"},{"issue":"25","key":"3397_CR34","doi-asserted-by":"crossref","first-page":"15183","DOI":"10.1016\/S0021-9258(18)77239-6","volume":"265","author":"H-P Hohmann","year":"1990","unstructured":"Hohmann H-P, Remy R, P\u00f6schl B, Van Loon A (1990) Tumor necrosis factors-alpha and-beta bind to the same two types of tumor necrosis factor receptors and maximally activate the transcription factor NF-kappa B at low receptor occupancy and within minutes after receptor binding. J Biol Chem 265(25):15183\u201315188","journal-title":"J Biol Chem"},{"issue":"Suppl 1","key":"3397_CR35","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.5213\/inj.1632604.302","volume":"20","author":"H Hong","year":"2016","unstructured":"Hong H, Kim BS, Im H-I (2016) Pathophysiological role of neuroinflammation in neurodegenerative diseases and psychiatric disorders. Int Neurourol J 20(Suppl 1):S2","journal-title":"Int Neurourol J"},{"issue":"4","key":"3397_CR36","doi-asserted-by":"crossref","first-page":"185","DOI":"10.32598\/irjns.7.4.3","volume":"7","author":"M Hoseinpourfard","year":"2021","unstructured":"Hoseinpourfard M, Nasehi M, Zarrindast MR, Izadi M, Nami M (2021) Evaluation of pain tolerance threshold following administration of anti-TNF-\u03b1 in REM sleep-deprived male Wistar rats. Iran J Neurosurg 7(4):185\u2013190","journal-title":"Iran J Neurosurg"},{"key":"3397_CR37","doi-asserted-by":"publisher","first-page":"577631","DOI":"10.1016\/j.jneuroim.2021.577631","volume":"357","author":"K Imabayashi","year":"2021","unstructured":"Imabayashi K, Ayano M, Higashioka K, Yokoyama K, Yamamoto K, Takayama K, Niiro H (2021) Infliximab for reversible dementia in acute onset of neuro-Beh\u00e7et\u2019s disease: a case report and cytokine analysis. J Neuroimmunol 357:577631. https:\/\/doi.org\/10.1016\/j.jneuroim.2021.577631","journal-title":"J Neuroimmunol"},{"issue":"1","key":"3397_CR38","first-page":"00274","volume":"8","author":"H Isa","year":"2018","unstructured":"Isa H, Ashoor M, Ali A, Mohamed HJJNS (2018) Infliximab Induced Leukoencephalopathy and Peripheral Neuropathy: a Case Report and a Review of Literature 8(1):00274","journal-title":"Infliximab Induced Leukoencephalopathy and Peripheral Neuropathy: a Case Report and a Review of Literature"},{"issue":"22","key":"3397_CR39","doi-asserted-by":"publisher","first-page":"14276","DOI":"10.3390\/ijms232214276","volume":"23","author":"S Jayanti","year":"2022","unstructured":"Jayanti S, Moretti R, Tiribelli C, Gazzin S (2022) Bilirubin prevents the TH(+) dopaminergic neuron loss in a Parkinson\u2019s disease model by acting on TNF-\u03b1. Int J Mol Sci 23(22):14276. https:\/\/doi.org\/10.3390\/ijms232214276","journal-title":"Int J Mol Sci"},{"issue":"5","key":"3397_CR40","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/bcpt.12037","volume":"112","author":"A Karson","year":"2013","unstructured":"Karson A, Demirta\u015f T, Bayramg\u00fcrler D, Balci F, Utkan T (2013) Chronic administration of infliximab (TNF-\u03b1 inhibitor) decreases depression and anxiety-like behaviour in rat model of chronic mild stress. Basic Clin Pharmacol Toxicol 112(5):335\u2013340. https:\/\/doi.org\/10.1111\/bcpt.12037","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"3","key":"3397_CR41","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2340\/00015555-1932","volume":"95","author":"K Kase","year":"2015","unstructured":"Kase K, Ishii-Osai Y, Sumikawa Y, Yoneta A, Himeno D, Kakutani Y, Yamashita T (2015) Rapidly developed neurosyphilis in a psoriasis patient under treatment with infliximab: a case report. Acta Derm Venereol 95(3):351\u2013352. https:\/\/doi.org\/10.2340\/00015555-1932","journal-title":"Acta Derm Venereol"},{"issue":"1\u20132","key":"3397_CR42","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jns.2008.05.002","volume":"272","author":"H Kikuchi","year":"2008","unstructured":"Kikuchi H, Aramaki K, Hirohata S (2008) Effect of infliximab in progressive neuro-Beh\u00e7et\u2019s syndrome. J Neurol Sci 272(1\u20132):99\u2013105. https:\/\/doi.org\/10.1016\/j.jns.2008.05.002","journal-title":"J Neurol Sci"},{"issue":"9","key":"3397_CR43","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1038\/cdd.2010.19","volume":"17","author":"J Kim","year":"2010","unstructured":"Kim J, Lee S, Park J, Yoo Y (2010) TNF-\u03b1-induced ROS production triggering apoptosis is directly linked to Romo1 and Bcl-XL. Cell Death Differ 17(9):1420\u20131434","journal-title":"Cell Death Differ"},{"key":"3397_CR44","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.bbr.2016.06.001","volume":"311","author":"DH Kim","year":"2016","unstructured":"Kim DH, Choi SM, Jho J, Park MS, Kang J, Park SJ, Kim BC (2016) Infliximab ameliorates AD-associated object recognition memory impairment. Behav Brain Res 311:384\u2013391. https:\/\/doi.org\/10.1016\/j.bbr.2016.06.001","journal-title":"Behav Brain Res"},{"key":"3397_CR45","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.bbi.2017.04.007","volume":"64","author":"GC Kincheski","year":"2017","unstructured":"Kincheski GC, Valentim IS, Clarke JR, Cozachenco D, Castelo-Branco MTL, Ramos-Lobo AM, Ferreira ST (2017) Chronic sleep restriction promotes brain inflammation and synapse loss, and potentiates memory impairment induced by amyloid-\u03b2 oligomers in mice. Brain Behav Immun 64:140\u2013151. https:\/\/doi.org\/10.1016\/j.bbi.2017.04.007","journal-title":"Brain Behav Immun"},{"key":"3397_CR46","doi-asserted-by":"crossref","first-page":"645","DOI":"10.2165\/00003088-200746080-00002","volume":"46","author":"U Klotz","year":"2007","unstructured":"Klotz U, Teml A, Schwab M (2007) Clinical pharmacokinetics and use of infliximab. Clin Pharmacokinet 46:645\u2013660","journal-title":"Clin Pharmacokinet"},{"issue":"36","key":"3397_CR47","doi-asserted-by":"crossref","first-page":"8240","DOI":"10.1523\/JNEUROSCI.1808-05.2005","volume":"25","author":"J Koenigsknecht-Talboo","year":"2005","unstructured":"Koenigsknecht-Talboo J, Landreth GE (2005) Microglial phagocytosis induced by fibrillar \u03b2-amyloid and IgGs are differentially regulated by proinflammatory cytokines. J Neurosci 25(36):8240\u20138249","journal-title":"J Neurosci"},{"issue":"3","key":"3397_CR48","doi-asserted-by":"publisher","first-page":"247","DOI":"10.22365\/jpsych.2021.011","volume":"32","author":"K Kontoangelos","year":"2021","unstructured":"Kontoangelos K, Economou M, Giannakopoulos O, Lazaratou H, Yiannopoulou KG, Papageorgiou C (2021) Suicidal thoughts in a patient after administration of infliximab. Psychiatriki 32(3):247\u2013250. https:\/\/doi.org\/10.22365\/jpsych.2021.011","journal-title":"Psychiatriki"},{"issue":"5","key":"3397_CR49","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1136\/jnnp-2011-301779","volume":"83","author":"R Krishnadas","year":"2012","unstructured":"Krishnadas R, Cavanagh J (2012) Depression: an inflammatory illness? J Neurol Neurosurg Psychiatry 83(5):495\u2013502","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"3397_CR50","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.acthis.2014.12.002","volume":"117","author":"H K\u00fcbraEl\u00e7io\u011flu","year":"2015","unstructured":"K\u00fcbraEl\u00e7io\u011flu H, Kabasakal L, Tufan F, El\u00e7io\u011flu \u00d6H, Solakoglu S, Kotil T, Karan MA (2015) Effects of systemic thalidomide and intracerebroventricular etanercept and infliximab administration in a streptozotocin induced dementia model in rats. Acta Histochem 117(2):176\u2013181. https:\/\/doi.org\/10.1016\/j.acthis.2014.12.002","journal-title":"Acta Histochem"},{"key":"3397_CR51","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.bbi.2020.04.063","volume":"88","author":"Y Lee","year":"2020","unstructured":"Lee Y, Mansur RB, Brietzke E, Carmona NE, Subramaniapillai M, Pan Z, McIntyre RS (2020) Efficacy of adjunctive infliximab vs. placebo in the treatment of anhedonia in bipolar I\/II depression. Brain Behav Immun 88:631\u2013639. https:\/\/doi.org\/10.1016\/j.bbi.2020.04.063","journal-title":"Brain Behav Immun"},{"issue":"4","key":"3397_CR52","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/00054725-200207000-00001","volume":"8","author":"GR Lichtenstein","year":"2002","unstructured":"Lichtenstein GR, Bala M, Han C, DeWoody K, Schaible T (2002) Infliximab improves quality of life in patients with Crohn\u2019s disease. Inflamm Bowel Dis 8(4):237\u2013243. https:\/\/doi.org\/10.1097\/00054725-200207000-00001","journal-title":"Inflamm Bowel Dis"},{"issue":"9","key":"3397_CR53","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/ecco-jcc\/jjv096","volume":"9","author":"L Lichtenstein","year":"2015","unstructured":"Lichtenstein L, Ron Y, Kivity S, Ben-Horin S, Israeli E, Fraser GM, Weiss B (2015) Infliximab-related infusion reactions: systematic review. J Crohn\u2019s Colitis 9(9):806\u2013815","journal-title":"J Crohn\u2019s Colitis"},{"issue":"1","key":"3397_CR54","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1684\/ecn.2015.0362","volume":"26","author":"YN Liu","year":"2015","unstructured":"Liu YN, Peng YL, Liu L, Wu TY, Zhang Y, Lian YJ, Wang YX (2015) TNF\u03b1 mediates stress-induced depression by upregulating indoleamine 2,3-dioxygenase in a mouse model of unpredictable chronic mild stress. Eur Cytokine Netw 26(1):15\u201325. https:\/\/doi.org\/10.1684\/ecn.2015.0362","journal-title":"Eur Cytokine Netw"},{"issue":"4","key":"3397_CR55","doi-asserted-by":"publisher","first-page":"26589","DOI":"10.4088\/PCC.15l01781","volume":"17","author":"MR Locher","year":"2015","unstructured":"Locher MR, Alam A (2015) Acute psychosis in an adolescent treated with infliximab for Crohn\u2019s disease. Prim Care Companion CNS Disord 17(4):26589. https:\/\/doi.org\/10.4088\/PCC.15l01781","journal-title":"Prim Care Companion CNS Disord"},{"issue":"6","key":"3397_CR56","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.cmet.2013.11.002","volume":"18","author":"MV Lourenco","year":"2013","unstructured":"Lourenco MV, Clarke JR, Frozza RL, Bomfim TR, Forny-Germano L, Batista AF, De Felice FG (2013) TNF-\u03b1 mediates PKR-dependent memory impairment and brain IRS-1 inhibition induced by Alzheimer\u2019s \u03b2-amyloid oligomers in mice and monkeys. Cell Metab 18(6):831\u2013843. https:\/\/doi.org\/10.1016\/j.cmet.2013.11.002","journal-title":"Cell Metab"},{"issue":"5","key":"3397_CR57","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3390\/ijms17050733","volume":"17","author":"K Ma","year":"2016","unstructured":"Ma K, Zhang H, Baloch Z (2016) Pathogenetic and therapeutic applications of tumor necrosis factor-\u03b1 (TNF-\u03b1) in major depressive disorder: a systematic review. Int J Mol Sci 17(5):733","journal-title":"Int J Mol Sci"},{"issue":"3","key":"3397_CR58","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/JCP.0b013e3181dcf0de","volume":"30","author":"DW Maas","year":"2010","unstructured":"Maas DW, Westendorp RG, Willems JM, de Craen AJ, van der Mast RC (2010) TNF-\u03b1 antagonist infliximab in the treatment of depression in older adults: results of a prematurely ended, randomized, placebo-controlled trial. J Clin Psychopharmacol 30(3):343\u2013345. https:\/\/doi.org\/10.1097\/JCP.0b013e3181dcf0de","journal-title":"J Clin Psychopharmacol"},{"issue":"4","key":"3397_CR59","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1002\/art.20159","volume":"50","author":"RN Maini","year":"2004","unstructured":"Maini RN, Breedveld FC, Kalden JR, Smolen JS, Furst D, Weisman MH, Lipsky PE (2004) Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate. Arthritis Rheum 50(4):1051\u20131065. https:\/\/doi.org\/10.1002\/art.20159","journal-title":"Arthritis Rheum"},{"key":"3397_CR60","doi-asserted-by":"publisher","unstructured":"Mansur RB, Delgado-Peraza F, Subramaniapillai M, Lee Y, Iacobucci M, Rodrigues N, Kapogiannis D (2020a) Extracellular vesicle biomarkers reveal inhibition of neuroinflammation by infliximab in association with antidepressant response in adults with bipolar depression. Cells 9(4):895. https:\/\/doi.org\/10.3390\/cells9040895","DOI":"10.3390\/cells9040895"},{"key":"3397_CR61","doi-asserted-by":"publisher","first-page":"104779","DOI":"10.1016\/j.psyneuen.2020.104779","volume":"120","author":"RB Mansur","year":"2020","unstructured":"Mansur RB, Subramaniapillai M, Lee Y, Pan Z, Carmona NE, Shekotikhina M, McIntyre RS (2020b) Leptin mediates improvements in cognitive function following treatment with infliximab in adults with bipolar depression. Psychoneuroendocrinology 120:104779. https:\/\/doi.org\/10.1016\/j.psyneuen.2020.104779","journal-title":"Psychoneuroendocrinology"},{"key":"3397_CR62","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jad.2020.11.128","volume":"281","author":"RB Mansur","year":"2021","unstructured":"Mansur RB, Subramaniapillai M, Lee Y, Pan Z, Carmona NE, Shekotikhina M, McIntyre RS (2021) Effects of infliximab on brain neurochemistry of adults with bipolar depression. J Affect Disord 281:61\u201366. https:\/\/doi.org\/10.1016\/j.jad.2020.11.128","journal-title":"J Affect Disord"},{"issue":"8","key":"3397_CR63","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1001\/jamapsychiatry.2019.0779","volume":"76","author":"RS McIntyre","year":"2019","unstructured":"McIntyre RS, Subramaniapillai M, Lee Y, Pan Z, Carmona NE, Shekotikhina M, Mansur RB (2019) Efficacy of adjunctive infliximab vs placebo in the treatment of adults with bipolar I\/II depression: a randomized clinical trial. JAMA Psychiat 76(8):783\u2013790. https:\/\/doi.org\/10.1001\/jamapsychiatry.2019.0779","journal-title":"JAMA Psychiat"},{"key":"3397_CR64","doi-asserted-by":"crossref","unstructured":"Melsheimer R, Geldhof A, Apaolaza I, Schaible T (2019) Remicade\u00ae(infliximab): 20 years of contributions to science and medicine. Biologics: Targets Ther 139\u2013178","DOI":"10.2147\/BTT.S207246"},{"issue":"5","key":"3397_CR65","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.jaad.2009.07.022","volume":"62","author":"A Menter","year":"2010","unstructured":"Menter A, Augustin M, Signorovitch J, Andrew PY, Wu EQ, Gupta SR, Mulani P (2010) The effect of adalimumab on reducing depression symptoms in patients with moderate to severe psoriasis: a randomized clinical trial. J Am Acad Dermatol 62(5):812\u2013818","journal-title":"J Am Acad Dermatol"},{"issue":"14","key":"3397_CR66","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.3748\/wjg.v13.i14.2089","volume":"13","author":"IM Minderhoud","year":"2007","unstructured":"Minderhoud IM, Samsom M, Oldenburg B (2007) Crohn\u2019s disease, fatigue, and infliximab: is there a role for cytokines in the pathogenesis of fatigue? World J Gastroenterol 13(14):2089\u20132093. https:\/\/doi.org\/10.3748\/wjg.v13.i14.2089","journal-title":"World J Gastroenterol"},{"issue":"18","key":"3397_CR67","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.2169\/internalmedicine.55.6872","volume":"55","author":"Y Miwa","year":"2016","unstructured":"Miwa Y, Isojima S, Saito M, Ikari Y, Kobuna M, Hayashi T, Sanada K (2016) Comparative study of infliximab therapy and methotrexate monotherapy to improve the clinical effect in rheumatoid arthritis patients. Intern Med 55(18):2581\u20132585. https:\/\/doi.org\/10.2169\/internalmedicine.55.6872","journal-title":"Intern Med"},{"key":"3397_CR68","doi-asserted-by":"publisher","first-page":"120613","DOI":"10.1016\/j.lfs.2022.120613","volume":"301","author":"HE Mohamad","year":"2022","unstructured":"Mohamad HE, Abo-Elmatty DM, Wahba NS, Shaheen MA, Sakr RT, Wahba AS (2022) Infliximab and\/or MESNA alleviate doxorubicin-induced Alzheimer\u2019s disease-like pathology in rats: a new insight into TNF-\u03b1\/Wnt\/\u03b2-catenin signaling pathway. Life Sci 301:120613. https:\/\/doi.org\/10.1016\/j.lfs.2022.120613","journal-title":"Life Sci"},{"issue":"1","key":"3397_CR69","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/intimm\/dxu102","volume":"27","author":"C Monaco","year":"2015","unstructured":"Monaco C, Nanchahal J, Taylor P, Feldmann M (2015) Anti-TNF therapy: past, present and future. Int Immunol 27(1):55\u201362","journal-title":"Int Immunol"},{"key":"3397_CR70","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.vph.2016.08.007","volume":"87","author":"C Nacci","year":"2016","unstructured":"Nacci C, Leo V, De Benedictis L, Potenza MA, Sgarra L, Maria A, Montagnani M (2016) Infliximab therapy restores adiponectin expression in perivascular adipose tissue and improves endothelial nitric oxide-mediated vasodilation in mice with type 1 diabetes. Vascul Pharmacol 87:83\u201391","journal-title":"Vascul Pharmacol"},{"issue":"9","key":"3397_CR71","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1002\/ibd.21202","volume":"16","author":"S Nancey","year":"2010","unstructured":"Nancey S, Bouhour F, Boschetti G, Magnier C, Gonneau PM, Souquet JC, Flourie B (2010) Lewis and Sumner syndrome following infliximab treatment in Crohn\u2019s disease: a report of 2 cases. Inflamm Bowel Dis 16(9):1450\u20131453. https:\/\/doi.org\/10.1002\/ibd.21202","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"3397_CR72","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1179\/acb.2007.035","volume":"62","author":"F Oguz","year":"2007","unstructured":"Oguz F, Oguz A, Uzunlulu M (2007) The effect of infliximab treatment on insulin resistance in patients with rheumatoid arthritis. Acta Clin Belg 62(4):218\u2013222","journal-title":"Acta Clin Belg"},{"issue":"1","key":"3397_CR73","first-page":"861231","volume":"2014","author":"G Olmos","year":"2014","unstructured":"Olmos G, Llad\u00f3 J (2014) Tumor necrosis factor alpha: a link between neuroinflammation and excitotoxicity. Mediat Inflamm 2014(1):861231","journal-title":"Mediat Inflamm"},{"key":"3397_CR74","first-page":"204062231983844","volume":"10","author":"K Papamichael","year":"2019","unstructured":"Papamichael K, Lin S, Moore M, Papaioannou G, Sattler L, Cheifetz AS (2019) Infliximab in inflammatory bowel disease. Ther Adv Chron Dis 10:2040622319838443","journal-title":"Ther Adv Chron Dis"},{"issue":"6","key":"3397_CR75","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jcyt.2019.04.054","volume":"21","author":"J Park","year":"2019","unstructured":"Park J, Lee S-Y, Shon J, Kim K, Lee HJ, Kim KA, Kim OJ (2019) Adalimumab improves cognitive impairment, exerts neuroprotective effects and attenuates neuroinflammation in an A\u03b21-40-injected mouse model of Alzheimer\u2019s disease. Cytotherapy 21(6):671\u2013682","journal-title":"Cytotherapy"},{"issue":"10","key":"3397_CR76","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1002\/ibd.20931","volume":"15","author":"E Parmentier-Decrucq","year":"2009","unstructured":"Parmentier-Decrucq E, Duhamel A, Ernst O, Fermont C, Louvet A, Vernier-Massouille G, Peyrin-Biroulet L (2009) Effects of infliximab therapy on abdominal fat and metabolic profile in patients with Crohn\u2019s disease. Inflamm Bowel Dis 15(10):1476\u20131484","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"3397_CR77","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1093\/rheumatology\/ker124","volume":"50","author":"D Pascual-Salcedo","year":"2011","unstructured":"Pascual-Salcedo D, Plasencia C, Ramiro S, Nuno L, Bonilla G, Nagore D, Mart\u00edn-Mola E (2011) Influence of immunogenicity on the efficacy of long-term treatment with infliximab in rheumatoid arthritis. Rheumatology 50(8):1445\u20131452","journal-title":"Rheumatology"},{"issue":"4","key":"3397_CR78","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1084\/jem.184.4.1397","volume":"184","author":"M Pasparakis","year":"1996","unstructured":"Pasparakis M, Alexopoulou L, Episkopou V, Kollias G (1996) Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J Exp Med 184(4):1397\u20131411","journal-title":"J Exp Med"},{"issue":"10","key":"3397_CR79","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1212\/01.wnl.0000034766.13282.33","volume":"59","author":"JA Pettersen","year":"2002","unstructured":"Pettersen JA, Zochodne DW, Bell RB, Martin L, Hill MD (2002) Refractory neurosarcoidosis responding to infliximab. Neurology 59(10):1660\u20131661. https:\/\/doi.org\/10.1212\/01.wnl.0000034766.13282.33","journal-title":"Neurology"},{"issue":"1","key":"3397_CR80","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1186\/s12876-022-02347-1","volume":"22","author":"L Peyrin-Biroulet","year":"2022","unstructured":"Peyrin-Biroulet L, Arkkila P, Armuzzi A, Danese S, Guardiola J, Jahnsen J, Reinisch W (2022) Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis. BMC Gastroenterol 22(1):291","journal-title":"BMC Gastroenterol"},{"key":"3397_CR81","doi-asserted-by":"publisher","first-page":"107917","DOI":"10.1016\/j.intimp.2021.107917","volume":"99","author":"F Poutoglidou","year":"2021","unstructured":"Poutoglidou F, Pourzitaki C, Manthou ME, Saitis A, Malliou F, Kouvelas D (2021) Infliximab and tocilizumab reduce anxiety-like behavior, improve cognitive performance and reverse neuropathological alterations in juvenile rats with severe autoimmune arthritis. Int Immunopharmacol 99:107917. https:\/\/doi.org\/10.1016\/j.intimp.2021.107917","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"3397_CR82","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s43440-021-00328-x","volume":"74","author":"F Poutoglidou","year":"2022","unstructured":"Poutoglidou F, Pourzitaki C, Manthou ME, Malliou F, Saitis A, Tsimoulas I, Kouvelas D (2022a) Effects of long-term infliximab and tocilizumab treatment on anxiety-like behavior and cognitive function in naive rats. Pharmacol Rep 74(1):84\u201395. https:\/\/doi.org\/10.1007\/s43440-021-00328-x","journal-title":"Pharmacol Rep"},{"issue":"1","key":"3397_CR83","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s10753-021-01560-6","volume":"45","author":"F Poutoglidou","year":"2022","unstructured":"Poutoglidou F, Pourzitaki C, Manthou ME, Saitis A, Malliou F, Kouvelas D (2022b) Infliximab and tocilizumab reduce anxiety-like behaviour and improve cognitive performance in a juvenile collagen-induced arthritis rat model. Inflammation 45(1):445\u2013459. https:\/\/doi.org\/10.1007\/s10753-021-01560-6","journal-title":"Inflammation"},{"issue":"1","key":"3397_CR84","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1001\/2013.jamapsychiatry.4","volume":"70","author":"CL Raison","year":"2013","unstructured":"Raison CL, Rutherford RE, Woolwine BJ, Shuo C, Schettler P, Drake DF, Miller AH (2013) A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiat 70(1):31\u201341. https:\/\/doi.org\/10.1001\/2013.jamapsychiatry.4","journal-title":"JAMA Psychiat"},{"issue":"1","key":"3397_CR85","first-page":"8430123","volume":"2018","author":"FR Rizzo","year":"2018","unstructured":"Rizzo FR, Musella A, De Vito F, Fresegna D, Bullitta S, Vanni V, Mandolesi G (2018) Tumor necrosis factor and interleukin-1\u03b2 modulate synaptic plasticity during neuroinflammation. Neural Plast 2018(1):8430123","journal-title":"Neural Plast"},{"issue":"6","key":"3397_CR86","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1007\/s10620-006-8007-x","volume":"51","author":"X Roblin","year":"2006","unstructured":"Roblin X, Oltean P, Heluwaert F, Bonaz B (2006) Panic attack with suicide: an exceptional adverse effect of infliximab. Dig Dis Sci 51(6):1056. https:\/\/doi.org\/10.1007\/s10620-006-8007-x","journal-title":"Dig Dis Sci"},{"key":"3397_CR87","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.bbr.2015.05.062","volume":"292","author":"TD \u015eahin","year":"2015","unstructured":"\u015eahin TD, Karson A, Balc\u0131 F, Yaz\u0131r Y, Bayramg\u00fcrler D, Utkan T (2015) TNF-alpha inhibition prevents cognitive decline and maintains hippocampal BDNF levels in the unpredictable chronic mild stress rat model of depression. Behav Brain Res 292:233\u2013240. https:\/\/doi.org\/10.1016\/j.bbr.2015.05.062","journal-title":"Behav Brain Res"},{"key":"3397_CR88","doi-asserted-by":"crossref","first-page":"117545","DOI":"10.1016\/j.lfs.2020.117545","volume":"250","author":"TD \u015eahin","year":"2020","unstructured":"\u015eahin TD, Gocmez SS, Duruksu G, Yazir Y, Utkan T (2020) Infliximab prevents dysfunction of the vas deferens by suppressing inflammation and oxidative stress in rats with chronic stress. Life Sci 250:117545","journal-title":"Life Sci"},{"issue":"3","key":"3397_CR89","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1159\/000343609","volume":"225","author":"R Saraceno","year":"2012","unstructured":"Saraceno R, Faleri S, Ruzzetti M, Centonze D, Chimenti S (2012) Prevalence and management of panic attacks during infliximab infusion in psoriatic patients. Dermatology 225(3):236\u2013241. https:\/\/doi.org\/10.1159\/000343609","journal-title":"Dermatology"},{"issue":"6","key":"3397_CR90","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.4049\/jimmunol.138.6.1786","volume":"138","author":"P Scheurich","year":"1987","unstructured":"Scheurich P, Thoma B, Ucer U, Pfizenmaier K (1987) Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-alpha: induction of TNF receptors on human T cells and TNF-alpha-mediated enhancement of T cell responses. J Immunol (Baltimore, Md.: 1950) 138(6):1786\u20131790","journal-title":"J Immunol (Baltimore, Md.: 1950)"},{"issue":"6","key":"3397_CR91","doi-asserted-by":"publisher","first-page":"e229","DOI":"10.1097\/pq9.0000000000000229","volume":"4","author":"M Shayowitz","year":"2019","unstructured":"Shayowitz M, Bressler M, Ricardo AP, Grudnikoff E (2019) Infliximab-induced depression and suicidal behavior in adolescent with Crohn\u2019s disease: case report and review of literature. Pediatr Qual Saf 4(6):e229. https:\/\/doi.org\/10.1097\/pq9.0000000000000229","journal-title":"Pediatr Qual Saf"},{"key":"3397_CR92","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.brainres.2010.10.053","volume":"1368","author":"JQ Shi","year":"2011","unstructured":"Shi JQ, Shen W, Chen J, Wang BR, Zhong LL, Zhu YW, Xu J (2011a) Anti-TNF-\u03b1 reduces amyloid plaques and tau phosphorylation and induces CD11c-positive dendritic-like cell in the APP\/PS1 transgenic mouse brains. Brain Res 1368:239\u2013247. https:\/\/doi.org\/10.1016\/j.brainres.2010.10.053","journal-title":"Brain Res"},{"issue":"6","key":"3397_CR93","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1111\/j.1532-5415.2011.03445.x","volume":"59","author":"JQ Shi","year":"2011","unstructured":"Shi JQ, Wang BR, Jiang WW, Chen J, Zhu YW, Zhong LL, Xu J (2011b) Cognitive improvement with intrathecal administration of infliximab in a woman with Alzheimer\u2019s disease. J Am Geriatr Soc 59(6):1142\u20131144. https:\/\/doi.org\/10.1111\/j.1532-5415.2011.03445.x","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"3397_CR94","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12969-023-00941-5","volume":"22","author":"R Shiari","year":"2024","unstructured":"Shiari R, Khalili M, Zeinali V, Shashaani N, Samami M, Moghaddamemami FH (2024) Local injection of infliximab into calcinosis lesions in patients with juvenile dermatomyositis (JDM): a clinical trial. Pediatr Rheumatol 22(1):2","journal-title":"Pediatr Rheumatol"},{"issue":"6","key":"3397_CR95","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/00019442-200506000-00005","volume":"13","author":"I-S Shin","year":"2005","unstructured":"Shin I-S, Carter M, Masterman D, Fairbanks L, Cummings JL (2005) Neuropsychiatric symptoms and quality of life in Alzheimer disease. Am J Geriatr Psychiatry 13(6):469\u2013474","journal-title":"Am J Geriatr Psychiatry"},{"issue":"2","key":"3397_CR96","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/bjc.12333","volume":"61","author":"S Shorey","year":"2022","unstructured":"Shorey S, Ng ED, Wong CH (2022) Global prevalence of depression and elevated depressive symptoms among adolescents: a systematic review and meta-analysis. Br J Clin Psychol 61(2):287\u2013305","journal-title":"Br J Clin Psychol"},{"key":"3397_CR97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1478-6354-13-S1-S2","volume":"13","author":"JS Smolen","year":"2011","unstructured":"Smolen JS, Emery P (2011) Infliximab: 12 years of experience. Arthritis Res Ther 13:1\u201318","journal-title":"Arthritis Res Ther"},{"key":"3397_CR98","doi-asserted-by":"crossref","unstructured":"Thabet M, Yahia WB, Fathallah N, Guiga A, Ghannouchi NJAP (2023) Infliximab-induced depression and Suicidal behaviour: a serious adverse event to consider","DOI":"10.22541\/au.169956765.58985984\/v1"},{"issue":"10","key":"3397_CR99","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1007\/s00520-008-0429-x","volume":"16","author":"AJ Tookman","year":"2008","unstructured":"Tookman AJ, Jones CL, DeWitte M, Lodge PJ (2008) Fatigue in patients with advanced cancer: a pilot study of an intervention with infliximab. Support Care Cancer 16(10):1131\u20131140. https:\/\/doi.org\/10.1007\/s00520-008-0429-x","journal-title":"Support Care Cancer"},{"issue":"3","key":"3397_CR100","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.1346-8138.2011.01459.x","volume":"39","author":"H Torii","year":"2012","unstructured":"Torii H, Sato N, Yoshinari T, Nakagawa H (2012) Dramatic impact of a Psoriasis Area and Severity Index 90 response on the quality of life in patients with psoriasis: an analysis of Japanese clinical trials of infliximab. J Dermatol 39(3):253\u2013259. https:\/\/doi.org\/10.1111\/j.1346-8138.2011.01459.x","journal-title":"J Dermatol"},{"issue":"Suppl 1","key":"3397_CR101","doi-asserted-by":"publisher","first-page":"S762","DOI":"10.1192\/j.eurpsy.2023.1607","volume":"66","author":"P Ulual","year":"2023","unstructured":"Ulual P, Burhan HS, G\u00fc\u00e7l\u00fc O (2023) Infliximab induced severe depression and suicidal thoughts in patient with bipolar disorder. Eur Psychiatry 66(Suppl 1):S762-3. https:\/\/doi.org\/10.1192\/j.eurpsy.2023.1607. (eCollection 2023 Mar)","journal-title":"Eur Psychiatry"},{"issue":"5288","key":"3397_CR102","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1126\/science.274.5288.787","volume":"274","author":"DJ Van Antwerp","year":"1996","unstructured":"Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM (1996) Suppression of TNF-\u03b1-induced apoptosis by NF-\u03baB. Science 274(5288):787\u2013789","journal-title":"Science"},{"issue":"6","key":"3397_CR103","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1080\/00207454.2018.1544130","volume":"129","author":"C Van Sanford","year":"2019","unstructured":"Van Sanford C, Obeidat AZ, Hagen M, Zabeti A (2019) A case of fatal invasive aspergillosis in a patient with neurosarcoidosis treated with infliximab. Int J Neurosci 129(6):619\u2013622. https:\/\/doi.org\/10.1080\/00207454.2018.1544130","journal-title":"Int J Neurosci"},{"issue":"2","key":"3397_CR104","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S2215-0366(15)00505-2","volume":"3","author":"D Vigo","year":"2016","unstructured":"Vigo D, Thornicroft G, Atun R (2016) Estimating the true global burden of mental illness. Lancet Psychiatry 3(2):171\u2013178","journal-title":"Lancet Psychiatry"},{"issue":"7","key":"3397_CR105","doi-asserted-by":"crossref","first-page":"4461","DOI":"10.4049\/jimmunol.181.7.4461","volume":"181","author":"V Vila-del Sol","year":"2008","unstructured":"Vila-del Sol V, Punzon C, Fresno M (2008) IFN-\u03b3-induced TNF-\u03b1 expression is regulated by interferon regulatory factors 1 and 8 in mouse macrophages. J Immunol 181(7):4461\u20134470","journal-title":"J Immunol"},{"issue":"40","key":"3397_CR106","doi-asserted-by":"crossref","first-page":"4711","DOI":"10.2174\/1381612825666190115121018","volume":"24","author":"R Wadhwa","year":"2018","unstructured":"Wadhwa R, Gupta R, Maurya PK (2018) Oxidative stress and accelerated aging in neurodegenerative and neuropsychiatric disorder. Curr Pharm Des 24(40):4711\u20134725","journal-title":"Curr Pharm Des"},{"key":"3397_CR107","doi-asserted-by":"publisher","first-page":"104777","DOI":"10.1016\/j.neuint.2020.104777","volume":"138","author":"SA Wahdan","year":"2020","unstructured":"Wahdan SA, El-Derany MO, Abdel-Maged AE, Azab SS (2020) Abrogating doxorubicin-induced chemobrain by immunomodulators IFN-beta 1a or infliximab: insights to neuroimmune mechanistic hallmarks. Neurochem Int 138:104777. https:\/\/doi.org\/10.1016\/j.neuint.2020.104777","journal-title":"Neurochem Int"},{"issue":"1","key":"3397_CR108","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/sj.cdd.4401189","volume":"10","author":"H Wajant","year":"2003","unstructured":"Wajant H, Pfizenmaier K, Scheurich P (2003) Tumor necrosis factor signaling. Cell Death Differ 10(1):45\u201365","journal-title":"Cell Death Differ"},{"issue":"4","key":"3397_CR109","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1007\/s00431-024-05437-2","volume":"183","author":"L Wang","year":"2024","unstructured":"Wang L, He M, Wang W, Li S, Zhao G (2024) Efficacy and safety of infliximab in the treatment of Kawasaki disease: a systematic review and meta-analysis. Eur J Pediatr 183(4):1765\u201376","journal-title":"Eur J Pediatr"},{"issue":"1","key":"3397_CR110","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s13075-020-02305-w","volume":"22","author":"C Webers","year":"2020","unstructured":"Webers C, Stolwijk C, Schiepers O, Schoonbrood T, van Tubergen A, Landew\u00e9 R, Boonen A (2020) Infliximab treatment reduces depressive symptoms in patients with ankylosing spondylitis: an ancillary study to a randomized controlled trial (ASSERT). Arthritis Res Ther 22(1):225. https:\/\/doi.org\/10.1186\/s13075-020-02305-w","journal-title":"Arthritis Res Ther"},{"key":"3397_CR111","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.bbi.2014.12.016","volume":"47","author":"JF Weinberger","year":"2015","unstructured":"Weinberger JF, Raison CL, Rye DB, Montague AR, Woolwine BJ, Felger JC, Miller AH (2015) Inhibition of tumor necrosis factor improves sleep continuity in patients with treatment resistant depression and high inflammation. Brain Behav Immun 47:193\u2013200. https:\/\/doi.org\/10.1016\/j.bbi.2014.12.016","journal-title":"Brain Behav Immun"},{"key":"3397_CR112","doi-asserted-by":"publisher","first-page":"109813","DOI":"10.1016\/j.neuropharm.2023.109813","volume":"245","author":"R Yao","year":"2024","unstructured":"Yao R, Man Y, Lu Y, Su Y, Zhou M, Wang S, Wang L (2024) Infliximab alleviates memory impairment in rats with chronic pain by suppressing neuroinflammation and restoring hippocampal neurogenesis. Neuropharmacology 245:109813. https:\/\/doi.org\/10.1016\/j.neuropharm.2023.109813","journal-title":"Neuropharmacology"},{"issue":"1","key":"3397_CR113","doi-asserted-by":"crossref","first-page":"75","DOI":"10.5505\/ejm.2022.84669","volume":"28","author":"K Y\u0131ld\u0131zhan","year":"2023","unstructured":"Y\u0131ld\u0131zhan K, G\u00fcne\u015f H, Task\u0131ran A\u015e (2023) Effect of anakinra and infliximab on oxidative stress and caspase activation in PTZ-induced acute seizure in rats. East J Med 28(1):75\u201381","journal-title":"East J Med"},{"issue":"21","key":"3397_CR114","doi-asserted-by":"crossref","first-page":"11516","DOI":"10.3390\/ijms222111516","volume":"22","author":"A Zawadzka","year":"2021","unstructured":"Zawadzka A, Cie\u015blik M, Adamczyk A (2021) The role of maternal immune activation in the pathogenesis of autism: a review of the evidence, proposed mechanisms and implications for treatment. Int J Mol Sci 22(21):11516","journal-title":"Int J Mol Sci"},{"issue":"5","key":"3397_CR115","doi-asserted-by":"publisher","first-page":"e258","DOI":"10.1212\/nxi.0000000000000258","volume":"3","author":"B Zeydan","year":"2016","unstructured":"Zeydan B, Uygunoglu U, Saip S, Demirci ON, Seyahi E, Ugurlu S, Kantarci OH (2016) Infliximab is a plausible alternative for neurologic complications of Beh\u00e7et disease. Neurol Neuroimmunol Neuroinflamm 3(5):e258. https:\/\/doi.org\/10.1212\/nxi.0000000000000258","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"12","key":"3397_CR116","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1172\/JCI200317790","volume":"111","author":"R Zhang","year":"2003","unstructured":"Zhang R, He X, Liu W, Lu M, Hsieh J-T, Min W (2003) AIP1 mediates TNF-\u03b1\u2013induced ASK1 activation by facilitating dissociation of ASK1 from its inhibitor 14-3-3. J Clin Investig 111(12):1933\u20131943","journal-title":"J Clin Investig"},{"key":"3397_CR117","unstructured":"Zhang G, Li W, Zhang J, Wang H, Yu R (2018a) Tumor necrosis factor-\u03b1 inhibitor infliximab alleviates cognitive impairment in mice with transient middle cerebral artery occlusion by decreasing indoleamine 2, 3-dioxygenase activity 756\u2013760"},{"key":"3397_CR118","doi-asserted-by":"publisher","first-page":"879","DOI":"10.2147\/ppa.S156883","volume":"12","author":"M Zhang","year":"2018","unstructured":"Zhang M, Zhang T, Hong L, Zhang C, Zhou J, Fan R, Zhong J (2018b) Improvement of psychological status after infliximab treatment in patients with newly diagnosed Crohn\u2019s disease. Patient Prefer Adherence 12:879\u2013885. https:\/\/doi.org\/10.2147\/ppa.S156883","journal-title":"Patient Prefer Adherence"},{"issue":"1","key":"3397_CR119","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2307\/3578643","volume":"201","author":"P Zhang","year":"2024","unstructured":"Zhang P, Abudunaibi M, Zhao Q, Wu Y, Aihaiti G, Wu S, Xu H (2024) Effect of infliximab on radiation-induced submandibular gland dysfunction in rats. Radiat Res 201(1):77\u201386","journal-title":"Radiat Res"},{"issue":"1\u20132","key":"3397_CR120","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.brainres.2004.11.014","volume":"1034","author":"JY Zou","year":"2005","unstructured":"Zou JY, Crews FT (2005) TNF\u03b1 potentiates glutamate neurotoxicity by inhibiting glutamate uptake in organotypic brain slice cultures: neuroprotection by NF\u03baB inhibition. Brain Res 1034(1\u20132):11\u201324","journal-title":"Brain Res"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03397-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-024-03397-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03397-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T09:46:46Z","timestamp":1739440006000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-024-03397-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,3]]},"references-count":120,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["3397"],"URL":"https:\/\/doi.org\/10.1007\/s00210-024-03397-w","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,3]]},"assertion":[{"value":"14 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This is a review study. The TUMS Research Ethics Committee has confirmed that no ethical approval is required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}